ExoticRx · exoticrx.com/drugs/ibrexafungerp
Brexafemme
Inhibits beta-1,3-D-glucan synthase at a site distinct from echinocandins. First oral glucan synthase inhibitor. Active against azole- and echinocandin-resistant Candida.
GI upset. Teratogenic — contraindicated in pregnancy. CYP3A4 interactions. Novel mechanism. No veterinary data.
Each ExoticRx dose rule is graded by the strength of its primary evidence — see the editorial process.
Free-tier preview — dog and cat dosing. Pro and Student unlock all 2 species including reptiles, birds, pocket pets, livestock, and equine.
| Species | Route | Dose | Frequency | Evidence | Source |
|---|---|---|---|---|---|
| Dog (Domestic) | PO | 5–10 mg/kg | q12h day 1, then q24h | Weak | Plumb's Veterinary Drug Handbook, 9th Ed |
| Cat (Domestic) | PO | 5–10 mg/kg | q12h day 1, then q24h | Weak | Plumb's Veterinary Drug Handbook, 9th Ed |
Upgrade to Pro or Student to access full drug details including mechanism of action, warnings, dose ranges, and frequency.
View PlansSource citations and evidence levels available on the live page. Reference only — verify against current literature before clinical use.